Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLUCLORIC: Clofarabine vs Fludarabine in Reduced Intensity Conditioning for AML
NCT05917405Phase 2Recruiting
- Sponsor
- CHU de Nantes
- Start
- Sep 2023
- Primary completion
- Sep 2028
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine in acute myeloid leukemia (AML), sponsored by CHU de Nantes. Started Sep 2023; status: recruiting.
02
Drugs
clofarabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT05917405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05917405.